To comfort that, exposure of three different NSCLC cell lines to IL-17 has also been reported to increase neoangiogenesis and to promote in vivo tumor growth in SCID mice through a CXCR-2-dependent mechanism. The gene discussed is IL17A; the disease is non-small cell lung carcinoma.